Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

8.360 +0.010 (+0.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,429,670
Open 8.300
Bid (Size) 8.310 (5)
Ask (Size) 8.400 (10)
Prev. Close 8.350
Today's Range 8.230 - 8.440
52wk Range 7.200 - 15.43
Shares Outstanding 185,583,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations for BioCryst Pharma's Future
 
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
BCRX earnings call for the period ending March 31, 2023. 
Via The Motley Fool

Performance

YTD
-26.99%
-26.99%
1 Month
-1.53%
-1.53%
3 Month
-5.43%
-5.43%
6 Month
-27.81%
-27.81%
1 Year
-19.69%
-19.69%

More News

Read More
Why BioCryst Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
Via Benzinga
Recap: BioCryst Pharma Q1 Earnings
Via Benzinga
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
Via InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why Shares of BioCryst Pharmaceuticals Jumped Today
Via The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sinking Today
Via The Motley Fool
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Biocryst Pharmaceuticals's Earnings Outlook
Via Benzinga
BioCryst Shelves Development Of Rare Blood Disorder Candidate
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sliding Today
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Expert Ratings for BioCryst Pharmaceuticals
Via Benzinga
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
Via Benzinga
TSLA Stock Price Prediction: What to Know as Analysts Slash Tesla Price Targets
Via InvestorPlace
Why Is Getaround (GETR) Stock Up 6% Today?
Via InvestorPlace
BCRX Stock Sinks as BioCryst Discontinues Drug Development
Via InvestorPlace
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.